This study examines the use of a risk matrix as a risk management framework for selecting comparable parties in transfer pricing benchmarking within multinational enterprises. Using a qualitative legal-practical approach, it analyses the OECD Guidelines (2022), academic literature and illustrative case studies. The findings show that a likelihood-impact risk matrix enables systematic screening of comparables: low-risk comparables form a core set, medium-risk comparables are retained with caution and high-risk comparables are excluded. This approach strengthens documentation, enhances transparency and reduces dispute and compliance risks, contributing to both transfer pricing theory and practice.
Reza Adrinata (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: